GenEdit pulls in $8.5 mln
Berkeley, California-based GenEdit Inc, a developer of next generation therapeutics for genetic diseases, has closed $8.5 million in funding. Data Collective Bio and SK Holdings led the round with participation from other investors that included Sequoia Capital and Bow Capital.
11 December 2018•1 min read
